Specialty Drugs Stocks List

Specialty Drugs Stocks Recent News

Date Stock Title
Jul 3 BIIB Top Stock Movers Now: Tesla, Paramount Global, Biogen, and More
Jul 3 BIIB Biogen completes $1.15bn HI-Bio acquisition to expand immunology presence
Jul 3 CVS Vltava Fund - CVS Health Corp.: Why We Sold CVS
Jul 3 CVS Down by 25%, Can CVS Health Bounce Back in the Second Half of The Year?
Jul 2 BIIB Eli Lilly Wins Long-Awaited Approval For Biogen-Rivaling Alzheimer's Drug
Jul 2 BIIB US Equities Markets End Higher Tuesday Following Fed Chair Powell's Comments
Jul 2 INZY Inozyme gets Fast Track status for candidate for rare calcification condition
Jul 2 BIIB Biogen (BIIB) Slipped on Lower-Than-Expected Revenue Growth
Jul 2 BIIB Biogen Completes Acquisition of Human Immunology Biosciences
Jul 2 INZY Inozyme Pharma Announces FDA Fast Track Designation for INZ-701 in ABCC6 Deficiency
Jul 1 BIIB 10 clinical trials to watch in the second half of 2024
Jun 30 CVS Is CVS Health Stock a Buy?
Jun 30 CVS Down Over 60%, Is Walgreens Boots Alliance a Bad-News Buy?
Jun 30 INZY Why Did Inozyme Pharma, Inc. (INZY) Get a Strong Buy Rating from Analysts?
Jun 29 CVS Rising drug costs force a third of Americans to leave prescriptions unfilled: report
Jun 28 CVS CVS Health (CVS) Gains As Market Dips: What You Should Know
Jun 28 CVS Walgreens plots bold comeback strategy, but the results will take time
Jun 28 CVS UnitedHealth, Humana seen as managed care beneficiaries in second Trump term
Jun 28 BIIB Biogen, Eisai launch Alzheimer's drug Leqembi in China
Jun 28 BIIB Eisai and Biogen launch LEQEMBI for Alzheimer’s in China
Specialty Drugs

Specialty drugs are medications that are used to treat complex and chronic conditions, such as cancer, multiple sclerosis, and rheumatoid arthritis. They are typically more expensive than traditional medications and require special handling, storage, and administration. Specialty drugs may also require special monitoring and close follow-up with a healthcare provider.

Browse All Tags